Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print

Dr Vijay Chandru

Vijay Chandru (PhD MIT 1982), Chairman and Managing Director, Strand Life Sciences, has three decades of experience straddling various geographies, academic environments and industries. He has co-authored a book in computational logic, over seventy peer-reviewed research papers and has edited several volumes to his credit. He was elected a Fellow of the Indian Academies of Sciences and Engineering and is also an Adjunct Faculty at the Centre for Biosystems Science and Engineering (BSSE) at IISc in Bangalore.

Latest Articles By Dr Vijay Chandru

Choosing The Right Genomics Lab: Taking A Step Towards Genetic Testing

Dr Vijay Chandru

The most important aspect before selecting a laboratory is to check for its accreditationby institutions such as the College of American Pathologists (CAP)

Read More

The Cancer Scare: Lifestyle and Its Effect

Dr Vijay Chandru

The obvious culprit in lung and oral cancers is tobacco, which has been known to cause cancer for a long time and most recently researchers have begun to investigate and find out how exactly this happens

Read More

The Cancer Scare: Lifestyle And Its Effect

Dr Vijay Chandru

Being aware of the risks that our lifestyle poses to our health is the first step in taking care of our body and preventing it from falling prey to various diseases

Read More

Genetic Counselling: The Benefits of an Early Risk Assessment

Dr Vijay Chandru

It can help to clear such doubts and misinformation that you might have

Read More

Liquid Biopsy: Orchestrating A Paradigm Shift In Monitoring Cancer

Dr Vijay Chandru

In India, these tests are available at a handful of certified laboratories like Strand NGS Labs. These tests can be prescribed by medical practitioners at any hospital

Read More

Liquid Biopsy Aided Genetic Analyses For Personalised Management Of Cancer

Dr Vijay Chandru

Genetic analyses are set to become important tests for therapies in many diseases, apart from cancer in the future. Liquid biopsy based DNA analyses, therefore, represent a huge leap forward in enabling delivery of healthcare

Read More